Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT03056456
Eligibility Criteria:
Inclusion Criteria:
* Male or female participants with Type 1 Diabetes Mellitus (T1DM) who are receiving insulin therapy via an approved insulin pump
* Have a screening body mass index (BMI) of greater than 18.5 to 33.0 kilograms per meter squared (kg/m²), inclusive
* Have medical and laboratory test results that are acceptable for the study
* Have had no episodes of severe hypoglycemia (requiring assistance in treatment by a second party) in the past 6 months
* Have venous access sufficient to allow for blood sampling
* Have provided written consent and are willing to follow study procedures and commit to the study duration
Exclusion Criteria:
* Are currently participating or recently participated in a clinical trial or any other type of medical research judged to be incompatible with this study
* Had blood loss of more than 500 milliliters (mL) within the last month
* Have known allergies to LY900014, insulin lispro, related compounds or any components in the study drug formulations
* Have previously participated or withdrawn from this study
* Have or used to have health problems or medical test results that, in the opinion of the doctor, could make it unsafe to participate, or could interfere with understanding the results of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03056456
Study Brief:
Protocol Section:
NCT03056456